Michael Hawrylycz

📖 Wiki Page

researcher730 wordssynced 2026-04-02

<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Michael Hawrylycz</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>Allen Institute for Brain Science</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>80</td>
</tr>

<tr>
<td class="label">Research Focus</td>
<td>[Alzheimer's Disease](/diseases/alzheimers)</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Computational Biology, Transcriptomics, Data Analysis, Neuroinformatics</td>
</tr>
</table>

Michael Hawrylycz

Overview

...

Michael Hawrylycz

Overview

Mermaid diagram (expand to render)

Michael Hawrylycz is a leading researcher in the field of neurodegenerative diseases, affiliated with Allen Institute for Brain Science. Their research focuses on Computational Biology, Transcriptomics, Data Analysis, Neuroinformatics, with particular emphasis on Alzheimer's Disease. With an h-index of 80, Hawrylycz is among the most cited researchers in the neuroscience field["@google2026"].

Hawrylycz's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease. Their research group has made significant contributions to the fields of Computational Biology, Transcriptomics, Data Analysis, Neuroinformatics, publishing in high-impact journals including Nature.

Based at Allen Institute for Brain Science, Hawrylycz collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.

Research Focus

Disease Areas

[Alzheimer's Disease](/diseases/alzheimers-disease)

Mechanisms of Interest

Computational Biology
Transcriptomics
Data Analysis
Neuroinformatics

Programmatic Emphasis

Hawrylycz's portfolio emphasizes mechanism-aware biomarker interpretation and translational hypothesis testing in Alzheimer's Disease[@long2019]. Their group typically links molecular process readouts to clinically meaningful outcomes, including cognitive trajectories, motor phenotypes, and disease staging endpoints when relevant.

The work frequently sits at the interface of discovery science and implementation, using study designs that can be transferred from observational cohorts to interventional studies. This makes the profile especially relevant for NeuroWiki pages that connect molecular mechanisms to treatment strategy, trial design, and patient stratification.

Methods and Data Strategy

Within the Computational Biology, Transcriptomics, Data Analysis, Neuroinformatics domain, this research profile is most aligned with multimodal integration: combining imaging, biofluid, genomic, and clinical metadata to derive robust disease signatures. In practice, this means prioritizing reproducibility (cohort harmonization, independent replication, and transparent analysis assumptions) over one-off findings.

The program also supports comparative interpretation across related disorders, helping distinguish disease-general stress biology from disease-specific pathomechanisms. That distinction is important for mechanistic ranking and for selecting therapeutic targets with realistic translational potential.

Translational Relevance

For NeuroWiki readers, the translational value of this researcher profile lies in three areas: first, operationalizing mechanism-informed biomarkers for diagnosis and progression tracking; second, identifying patient subgroups most likely to respond to targeted interventions; and third, connecting preclinical hypotheses to trial-ready outcome frameworks.

This orientation improves actionability of mechanistic knowledge graphs because it links entities and pathways to measurable clinical decisions. Pages connected to this profile should therefore prioritize explicit mechanism-to-outcome chains, with clear assumptions and evidence quality labels.

Key Publications

[An anatomically comprehensive atlas of the adult human brain transcriptome](https://doi.org/10.1038/nature11405). Nature, 2012.[@anatomically2012]

[Genome-wide atlas of gene expression in the adult mouse brain](https://doi.org/10.1038/nature05453). Nature, 2007.[@genomewide2007]

Recent Research

Recent PubMed-indexed publications (2024-present):

[An Integrated Single-Cell and Epigenomic Resource for Comparative Analysis of the Basal Ganglia.](https://pubmed.ncbi.nlm.nih.gov/41659532/). bioRxiv : the preprint server for biology. 2026.

[The Caudate Nucleus Exhibits Distinct Pathology and Cell Type-Specific Responses Across Alzheimer's Disease.](https://pubmed.ncbi.nlm.nih.gov/41542441/). bioRxiv : the preprint server for biology. 2026.

[Accelerating biomedical discoveries in brain health through transformative neuropathology of aging and neurodegeneration.](https://pubmed.ncbi.nlm.nih.gov/40683248/). Neuron. 2025.

[Integrating multimodal data to understand cortical circuit architecture and function.](https://pubmed.ncbi.nlm.nih.gov/40128391/). Nature neuroscience. 2025.

Collaborators and Research Network

[Ed Lein](/researchers/ed-lein), [Hongkui Zeng](/researchers/hongkui-zeng)

Institutional Context

Primary institutional links: [Allen Institute for Brain Science](/institutions/allen-institute-for-brain-science). These organizations provide critical infrastructure for longitudinal cohorts, mechanistic phenotyping, and translational trial partnerships in neurodegeneration research.

Open Questions and Future Directions

How can Computational Biology, Transcriptomics, Data Analysis, Neuroinformatics signals be standardized across cohorts and sites without losing disease-stage sensitivity?
Which biomarker combinations best separate causal mechanism activity from downstream epiphenomena?
What trial designs can most efficiently translate mechanistic findings in Alzheimer's Disease into clinically meaningful interventions?

External Links

Google Scholar: [Search for Michael Hawrylycz](https://scholar.google.com/scholar?q=author%3A%22Michael+Hawrylycz%22)
PubMed: [Author search for Michael Hawrylycz](https://pubmed.ncbi.nlm.nih.gov/?term=Michael+Hawrylycz%5BAuthor%5D)

References

[Unknown, An anatomically comprehensive atlas of the adult human brain transcriptome (2012)](https://doi.org/10.1038/nature11405)

[Unknown, Genome-wide atlas of gene expression in the adult mouse brain (2007)](https://doi.org/10.1038/nature05453)

Unknown, Google Scholar author search for Michael Hawrylycz (2026)

[Unknown, Long and Holtzman, Alzheimer disease an update on pathobiology and treatment strategies 2019 (2019)](https://pubmed.ncbi.nlm.nih.gov/30617256/)

📖 View canonical wiki page →

Michael Hawrylycz

Michael Hawrylycz

Overview

Michael Hawrylycz

Overview

Research Focus

Disease Areas

Mechanisms of Interest

Programmatic Emphasis

Methods and Data Strategy

Translational Relevance

Key Publications

Recent Research

Collaborators and Research Network

Institutional Context

Open Questions and Future Directions

External Links

See Also

References